BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (AVI), a leader in advanced vascular access solutions, today announced that the U.S. Food and Drug Administration (FDA) cleared a new indication for its single-lumen MIMIX® HydroMid® and single- and dual-lumen HydroPICC® catheter lines. The updated labeling recognizes the devices’ proprietary hydrogel material as having anti-thrombogenic properties designed to reduce the risk of thrombus formation on catheter surfaces. “The MIMIX® HydroMi